The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
Abstract
CONTEXT: Sodium-glucose cotransporter 2 (SGLT2) expressed in the proximal renal tubules accounts for about 90% of the reabsorption of glucose from tubular fluid. Genetic defects of SGLT2 result in a benign familial renal glucosuria. Pharmacological agents that block SGLT2 are being tested as potential treatment for type 2 diabetes mellitus. EVIDENCE ACQUISITION: A Pubmed search was used to identify all relevant articles on the physiology of SGLTs as well as published preclinical and clinical experimental studies with SGLT2 inhibitors; a reference search of all retrieved articles was also undertaken. EVIDENCE SYNTHESIS: SGLT2 is almost exclusively expressed in the proximal renal tubules. Preclinical studies with selective SLGT2 inhibitors show dose-dependent glucosuria and lowering of blood glucose in models of type 2 diabetes. Preliminary clinical studies of up to 3-month duration show dose-dependent lowering of glycosylated hemoglobin up to 0.9% along with modest weight loss. Side effects include an increase in genital fungal infection compared to placebo, increased urine volume (300-400 ml/24 h), and evidence of volume depletion consistent with mild diuretic effect. CONCLUSION: SGLT2 inhibitors are showing promise as a useful addition to the current therapeutic options in type 2 diabetes mellitus. Results of ongoing phase III clinical trials are awaited and will determine whether the risk-benefit ratio will allow approval of this new class of drug for the management of type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ehrenkranz, J. R. L., Lewis, N. G., Ronald Kahn, C., & Roth, J. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.532 · Cited by 930
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
Wood, I. S., & Trayhurn, P. (2003) · British Journal of Nutrition · doi:10.1079/bjn2002763 · Cited by 889
Rossetti, L., Smith, D., Shulman, G. I., Papachristou, D., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112981 · Cited by 809
Rahmoune, H., Thompson, P. W., Ward, J. M., Smith, C. D., Hong, G., & Brown, J. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3427 · Cited by 777
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
List, J. F., Woo, V., Morales, E., Tang, W., & Fiedorek, F. T. (2009) · Diabetes Care · doi:10.2337/dc08-1863 · Cited by 698
Meng, W., Ellsworth, B. A., Nirschl, A. A., McCann, P. J., Patel, M., Girotra, R. N., Wu, G., Sher, P. M., Morrison, E. P., Biller, S. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701272q · Cited by 634 · cited 1×
“0 h in rats, dogs, and monkeys, respectively (45).”
BackgroundKanai, Y., Lee, W. S., You, G., Brown, D., & Hediger, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116972 · Cited by 630
The sodium/glucose cotransport family SLC5
Wright, E. M., & Turk, E. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1202-0 · Cited by 537
The SLC2 family of facilitated hexose and polyol transporters
Uldry, M., & Thorens, B. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1085-0 · Cited by 501
Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
Han, S., Hagan, D. L., Taylor, J. R., Xin, L., Meng, W., Biller, S. A., Wetterau, J. R., Washburn, W. N., & Whaley, J. M. (2008) · Diabetes · doi:10.2337/db07-1472 · Cited by 421
Wilding, J. P. H., Norwood, P., T'joen, C., Bastien, A., List, J. F., & Fiedorek, F. T. (2009) · Diabetes Care · doi:10.2337/dc09-0517 · Cited by 363
Self-citationDapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
Komoroski, B., Vachharajani, N., Boulton, D., Kornhauser, D., Geraldes, M., Li, L., & Pfister, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.251 · Cited by 350
Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
Rossetti, L., Shulman, G. I., Zawalich, W., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113157 · Cited by 330
Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria
Santer, R., Kinner, M., Lassen, C. L., Schneppenheim, R., Eggert, P., Bald, M., Brodehl, J., Daschner, M., Ehrich, J. H. H., Kemper, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092790.89332.d2 · Cited by 305
Martín, M. G., Turk, E., Lostao, M. P., Kerner, C., & Wright, E. M. (1996) · Nature Genetics · doi:10.1038/ng0296-216 · Cited by 278
Katsuno, K., Fujimori, Y., Takemura, Y., Hiratochi, M., Itoh, F., Komatsu, Y., Fujikura, H., & Isaji, M. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110296 · Cited by 267
Oku, A., Ueta, K., Arakawa, K., Ishihara, T., Nawano, M., Kuronuma, Y., Matsumoto, M., Saito, A., Tsujihara, K., Anai, M., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1794 · Cited by 254
Heuvel, L. V. D., K., A., M., W., & L., M. (2002) · Human Genetics · doi:10.1007/s00439-002-0820-5 · Cited by 223
Fujimori, Y., Katsuno, K., Nakashima, I., Ishikawa-Takemura, Y., Fujikura, H., & Isaji, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140210 · Cited by 221
Turner, R. J., & Moran, A. (1982) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1982.242.4.f406 · Cited by 221
Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)
Zhou, L., Cryan, E. V., D'Andrea, M. R., Belkowski, S., Conway, B. R., & Demarest, K. T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10631 · Cited by 206
Freitas, H. S., Anhê, G. F., Melo, K. F. S., Okamoto, M. M., Oliveira-Souza, M., Bordin, S., & Machado, U. F. (2008) · Endocrinology · doi:10.1210/en.2007-1088 · Cited by 192
Risk factors for symptomatic urinary tract infection in women with diabetes.
Geerlings, S. E., Stolk, R. P., Camps, M. J., Netten, P. M., Collet, T. J., Hoepelman, A. I., & Diabetes Women Asymptomatic Bacteriuria Utrecht Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1737 · Cited by 185
Kahn, B. B., Shulman, G. I., DeFronzo, R. A., Cushman, S. W., & Rossetti, L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115031 · Cited by 171
Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter
Wells, R. G., Pajor, A. M., Kanai, Y., Turk, E., Wright, E. M., & Hediger, M. A. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.3.f459 · Cited by 166
Panayotova-Heiermann, M., Loo, D. D. F., & Wright, E. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27099 · Cited by 165
HOEPELMAN, A. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00234-6 · Cited by 162
Washburn, W. N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013019 · Cited by 160
Structure of the human Na+/glucose cotransporter gene SGLT1.
Turk, E., Martín, M. G., & Wright, E. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36592-4 · Cited by 132
Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats
Dominguez, J. H., Camp, K., Maianu, L., Feister, H. A., & Garvey, W. T. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.2.f283 · Cited by 113
Calado, J., Sznajer, Y., Metzger, D. L., Rita, A., Hogan, M. C., Kattamis, A. C., Scharf, M., Tasic, V. B., Greil, J., Brinkert, F., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn386 · Cited by 112
Familial renal glycosuria: a genetic reappraisal of hexose transport by kidney and intestine
Elsas, L. J., & Rosenberg, L. E. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106150 · Cited by 101
Tsujihara, K., Hongu, M., SAITO, K., Inamasu, M., ARAKAWA, K., Oku, A., & MATSUMOTO, M. (1996) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.44.1174 · Cited by 96
Ueta, K., Ishihara, T., Matsumoto, Y., Oku, A., Nawano, M., Fujita, T., Saito, A., & Arakawa, K. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.09.038 · Cited by 84
Overexpression of GLUT2 gene in renal proximal tubules of diabetic Zucker rats.
Kamran, M., Peterson, R. G., & Dominguez, J. H. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v86943 · Cited by 84
Chin, E., Zamah, A. M., Landau, D., Grønbæk, H., Flyvbjerg, A., LeRoith, D., & Bondy, C. A. (1997) · Endocrinology · doi:10.1210/endo.138.3.5015 · Cited by 81
Angiotensin II-dependent increased expression of Na + -glucose cotransporter in hypertension
Bautista, R., Manning, R., Martínez-Morales, F., Ávila-Casado, M. D. C., Soto, V., Medina, A., & Escalante, B. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00113.2003 · Cited by 72
Treatment of Vulvovaginal Candidiasis in Patients With Diabetes
Bohannon, N. J. V. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.451 · Cited by 67
Molecular evidence for two renal Na+/glucose cotransporters
Pajor, A. M., Hirayama, B. A., & Wright, E. M. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90241-d · Cited by 60
Starke, A. A. R., Grundy, S. M., McGarry, J., & Unger, R. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.5.1544 · Cited by 58
Complete absence of tubular glucose reabsorption: a new type of renal glucosuria (type 0).
Oemar, B. S., Byrd, D. J., & Brodehl, J. (1987) · PubMed · Cited by 55
Li, H., Gu, Y., Zhang, Y., Lucas, M. J., & Wang, Y. (2004) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2003.08.002 · Cited by 51
Shi, Z. Q., Rastogi, K. S., Lekas, M. C., Efendić, S., Drucker, D. J., & Vranić, M. (1996) · Endocrinology · doi:10.1210/endo.137.8.8754739 · Cited by 45
Bickel, M., Brummerhop, H., Frick, W., Glombik, H., Herling, A. W., Heuer, H., Plettenburg, O., Theis, S., Ulrich, W., & Kramer, W. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296559 · Cited by 27
Design and synthesis of fluorescent SGLT2 inhibitors
Lansdell, M. I., Burring, D. J., Hepworth, D., Strawbridge, M., Graham, E. J. S., Guyot, T., Betson, M. S., & Hart, J. D. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.036 · Cited by 12
THE TREATMENT OF ACUTE AND CHRONIC VAGINAL CANDIDOSIS
SCUDAMORE, J. A., Tooley, P., & Allcorn, R. J. (1992) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1992.tb10361.x · Cited by 10
Cited by
Bolinder, J., Ljunggren, Ö., Kullberg, J., Johansson, L., Wilding, J., Langkilde, A. M., Sugg, J., & Parikh, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2260 · Cited by 867
“SGLT2 inhibitors are a new class of oral antidiabetic drugs, which reduce hyperglycemia by increasing urinary glucose excretion independently of insulin secretion or action (9).”
BackgroundSelf-citationBonner, C., Kerr-Conte, J., Gmyr, V., Queniat, G., Moerman, E., Thévenet, J., Beaucamps, C., Delalleau, N., Popescu, I., Malaisse, W. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3828 · Cited by 670
Grempler, R., Thomas, L., Eckhardt, M., Himmelsbach, F., Sauer, A., Sharp, D. E., Bakker, R. A., Mark, M., Klein, T., & Eickelmann, P. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01517.x · Cited by 608
Vallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483
Delost, M. D., Smith, D. T., Anderson, B. J., & Njardarson, J. T. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00876 · Cited by 409
Metadata
- Authors
- Nair, S., & Wilding, J. P. H.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-01
- Volume
- 95
- Issue
- 1
- Pages
- 34-42
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090088543
- Cited by
- 263
- References
- 46
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.